C57BL/6N-Atm1Brd Arpc1btm1a(EUCOMM)Wtsi/WtsiBiat

Status

Available to order

EMMA IDEM:05965
International strain nameC57BL/6N-Atm1Brd Arpc1btm1a(EUCOMM)Wtsi/WtsiBiat
Alternative nameEPD0423_1_B04
Strain typeTargeted Mutant Strains
Allele/Transgene symbolArpc1btm1a(EUCOMM)Wtsi
Gene/Transgene symbolArpc1b
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0423_1_B04. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria

Disease and phenotype information

IMPC phenotypes (allele matching)
  • increased circulating calcium level / IMPC
  • increased leukocyte cell number / IMPC
  • decreased body length / IMPC
  • increased mean platelet volume / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • decreased macrophage cell number / IMPC
  • vertebral fusion / IMPC
  • fusion of vertebral arches / IMPC
  • decreased circulating serum albumin level / IMPC
  • thrombocytosis / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • increased circulating total protein level / IMPC
  • decreased NK cell number / IMPC
  • decreased CD4-positive, alpha-beta T cell number / IMPC
  • increased plasma cell number / IMPC
  • decreased transitional stage T2 B cell number / IMPC
  • increased red blood cell distribution width / IMPC
  • decreased circulating fructosamine level / IMPC
  • increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • increased CD4-positive, alpha-beta memory T cell number / IMPC
  • decreased KLRG1-positive NK cell number / IMPC
  • increased KLRG1+ CD4 alpha-beta T cell number / IMPC
  • increased memory-marker NK cell number / IMPC
  • increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • increased memory-marker CD4-negative NK T cell number / IMPC
  • increased CD103-positive CD11b-low dendritic cell number / IMPC
  • increased immature NK cell number / IMPC
  • decreased mature NK cell number / IMPC
  • decreased Ly6C-positive mature NK cell number / IMPC
  • decreased marginal zone precursor B cell number / IMPC
  • increased effector memory T-helper cell number / IMPC
  • increased KLRG1-positive T-helper cell number / IMPC
  • atrophy / IMPC
  • process of degenerative change / IMPC
  • glomerulonephritis / IMPC
  • vasculitis / IMPC
  • inflammation / IMPC
IMPC phenotypes (gene matching)
  • increased CD4-positive, alpha-beta memory T cell number / IMPC
  • increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • increased effector memory T-helper cell number / IMPC
  • increased leukocyte cell number / IMPC
  • increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • process of degenerative change / IMPC
  • increased KLRG1-positive T-helper cell number / IMPC
  • increased memory-marker CD4-negative NK T cell number / IMPC
  • increased red blood cell distribution width / IMPC
  • increased circulating calcium level / IMPC
  • decreased mature NK cell number / IMPC
  • decreased marginal zone precursor B cell number / IMPC
  • glomerulonephritis / IMPC
  • decreased body length / IMPC
  • thrombocytosis / IMPC
  • decreased circulating serum albumin level / IMPC
  • atrophy / IMPC
  • decreased transitional stage T2 B cell number / IMPC
  • increased KLRG1+ CD4 alpha-beta T cell number / IMPC
  • increased circulating total protein level / IMPC
  • increased immature NK cell number / IMPC
  • increased plasma cell number / IMPC
  • increased memory-marker NK cell number / IMPC
  • fusion of vertebral arches / IMPC
  • decreased CD4-positive, alpha-beta T cell number / IMPC
  • decreased KLRG1-positive NK cell number / IMPC
  • inflammation / IMPC
  • increased CD103-positive CD11b-low dendritic cell number / IMPC
  • increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • decreased Ly6C-positive mature NK cell number / IMPC
  • decreased NK cell number / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • decreased macrophage cell number / IMPC
  • vertebral fusion / IMPC
  • vasculitis / IMPC
  • decreased circulating fructosamine level / IMPC
  • increased mean platelet volume / IMPC

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).